Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 5:39 PM View:  | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 04-Mar-24 | Sale | 4,573 | $1.53 | $6,985.71 | (4%) 129.41K to 124.84K | |
| 05-Mar-24 5:40 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 04-Mar-24 | Sale | 6,095 | $1.53 | $9,310.72 | (2%) 286.09K to 280.0K | |
| 05-Mar-24 5:40 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 01-Mar-24 | Sale | 6,770 | $1.53 | $10,341.90 | (5%) 125.14K to 118.37K | |
| 06-Feb-24 4:07 PM View: | Vittiglio Joseph Chief Business & Legal Officer | Bluebird Bio, Inc. (BLUE) | 05-Feb-24 | Sale | 5,217 | $0.90 | $4,708.34 | (10%) 50.0K to 44.78K | |
| 06-Feb-24 4:07 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 05-Feb-24 | Sale | 2,714 | $0.90 | $2,449.39 | (2%) 132.13K to 129.41K | |
| 06-Feb-24 4:07 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 05-Feb-24 | Sale | 1,879 | $0.90 | $1,695.80 | (< 1%) 287.97K to 286.09K | |
| 09-Jan-24 4:05 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 05-Jan-24 | Sale | 597 | $1.41 | $844.76 | (< 1%) 125.73K to 125.14K | |
| 09-Jan-24 4:05 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 05-Jan-24 | Sale | 3,162 | $1.43 | $4,519.76 | (1%) 291.13K to 287.97K | |
| 08-Dec-23 4:42 PM View: | Krawtschuk Christopher Chief Financial Officer | Bluebird Bio, Inc. (BLUE) | 06-Dec-23 | Sale | 4,526 | $4.52 | $20,437.20 | (9%) 50.0K to 45.47K | |
| 03-Nov-23 4:10 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 03-Nov-23 | Sale | 807 | $3.17 | $2,554.88 | (< 1%) 291.94K to 291.13K | |
| 03-Nov-23 4:10 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 02-Nov-23 | Sale | 2,343 | $2.98 | $6,974.88 | (2%) 128.08K to 125.73K | |
| 06-Sep-23 4:30 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 05-Sep-23 | Sale | 922 | $3.79 | $3,493.09 | (< 1%) 133.05K to 132.13K | |
| 10-Aug-23 5:00 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 10-Aug-23 | Sale | 16,929 | $3.54 | $59,955.70 | (5%) 308.87K to 291.94K | |
| 20-Jun-23 4:30 PM View: | Jones-Burton Charlotte Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 139% 7.77K to 18.56K | |
| 20-Jun-23 4:31 PM View: | Leschly Nick Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 2% 448.85K to 459.64K | |
| 20-Jun-23 4:31 PM View: | Tita-Reid Najoh Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 87% 12.47K to 23.26K | |
| 20-Jun-23 4:31 PM View: | Vachon Mark Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 76% 14.25K to 25.04K | |
| 20-Jun-23 4:31 PM View: | Agwunobi John O Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 69% 15.67K to 26.46K | |
| 20-Jun-23 4:30 PM View: | Leiderman Elisabeth Director | Bluebird Bio, Inc. (BLUE) | 16-Jun-23 | Grant | 10,790 | -- | -- | 94% 11.47K to 22.26K | |
| 06-Jun-23 4:06 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 02-Jun-23 | Sale | 4,130 | $3.50 | $14,450.90 | (3%) 137.18K to 133.05K | |
| 05-Apr-23 4:07 PM View: | Paulson Richard A. Director | Bluebird Bio, Inc. (BLUE) | 03-Apr-23 | Grant | 4,663 | -- | -- | 100% 0 to 4.66K | |
| 03-Mar-23 4:43 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 01-Mar-23 | Grant | 67,600 | -- | -- | 28% 241.27K to 308.87K | |
| 03-Mar-23 4:43 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 01-Mar-23 | Grant | 55,000 | -- | -- | 67% 82.18K to 137.18K | |
| 03-Mar-23 4:43 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 01-Mar-23 | Grant | 55,000 | -- | -- | 75% 73.08K to 128.08K | |
| 03-Feb-23 4:05 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 01-Feb-23 | Payment of Exercise | 1,153 | $6.38 | $7,356.14 | (2%) 74.23K to 73.08K | |
| 03-Feb-23 4:05 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 01-Feb-23 | Payment of Exercise | 1,420 | $6.38 | $9,059.60 | (< 1%) 242.69K to 241.27K | |
| 03-Feb-23 4:06 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 01-Feb-23 | Payment of Exercise | 2,260 | $6.38 | $14,418.80 | (3%) 84.44K to 82.18K | |
| 03-Feb-23 10:00 PM View: | Vittiglio Joseph Chief Business & Legal Officer | Bluebird Bio, Inc. (BLUE) | 01-Feb-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 13-Jan-23 4:19 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 11-Jan-23 | Sale | 3,178 | $7.80 | $24,802.10 | (1%) 245.87K to 242.69K | |
| 13-Jan-23 4:19 PM View: | Leschly Nick Director | Bluebird Bio, Inc. (BLUE) | 11-Jan-23 | Sale | 4,290 | $7.80 | $33,480.40 | (< 1%) 453.14K to 448.85K | |
| 13-Jan-23 4:19 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 11-Jan-23 | Sale | 557 | $7.80 | $4,347.00 | (< 1%) 74.79K to 74.23K | |
| 05-Dec-22 4:49 PM View: | Krawtschuk Christopher Chief Financial Officer | Bluebird Bio, Inc. (BLUE) | 01-Dec-22 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 08-Nov-22 5:46 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 04-Nov-22 | Sale | 1,263 | $6.41 | $8,100.50 | (< 1%) 247.13K to 245.87K | |
| 08-Nov-22 5:46 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 04-Nov-22 | Sale | 218 | $6.41 | $1,398.19 | (< 1%) 75.01K to 74.79K | |
| 03-Nov-22 4:19 PM View: | Colvin Richard A Chief Medical Officer | Bluebird Bio, Inc. (BLUE) | 01-Nov-22 | Grant | 30,000 | -- | -- | 67% 45.01K to 75.01K | |
| 09-Mar-23 4:06 PM View: | Leiderman Elisabeth Director | Bluebird Bio, Inc. (BLUE) | 17-Oct-22 | Sale | 1,004 | $6.46 | $6,490.16 | (8%) 12.47K to 11.47K | |
| 06-Sep-22 5:26 PM View: | Klima Thomas J See Remarks | Bluebird Bio, Inc. (BLUE) | 01-Sep-22 | Grant | 11,000 | -- | -- | 15% 71.44K to 82.44K | |
| 23-Aug-22 4:50 PM View: | Cole Jason Chief Strategy & Financial Off | Bluebird Bio, Inc. (BLUE) | 19-Aug-22 | Sale | 14,194 | $5.53 | $78,473.00 | (7%) 203.74K to 189.55K | |
| 08-Aug-22 4:16 PM View: | Cole Jason Chief Strategy & Financial Off | Bluebird Bio, Inc. (BLUE) | 04-Aug-22 | Sale | 7,448 | $4.39 | $32,707.10 | (4%) 211.19K to 203.74K | |
| 08-Aug-22 4:16 PM View: | Obenshain Andrew President and CEO Director | Bluebird Bio, Inc. (BLUE) | 04-Aug-22 | Sale | 21,805 | $4.39 | $95,754.50 | (8%) 268.94K to 247.13K | |
| 14-Jul-22 4:15 PM View: | Eggimann Anne-Virginie Chief Regulatory Officer | Bluebird Bio, Inc. (BLUE) | 12-Jul-22 | Sale | 1,358 | $4.95 | $6,722.10 | (3%) 43.61K to 42.25K | |
| 23-Jun-22 6:08 PM View: | Tita-Reid Najoh Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 3,109 | -- | -- | 33% 9.36K to 12.47K | |
| 23-Jun-22 6:09 PM View: | Vachon Mark Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 4,353 | -- | -- | 44% 9.9K to 14.25K | |
| 23-Jun-22 6:08 PM View: | Agwunobi John O Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 3,109 | -- | -- | 25% 12.56K to 15.67K | |
| 23-Jun-22 6:08 PM View: | Leiderman Elisabeth Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 3,109 | -- | -- | 33% 9.36K to 12.47K | |
| 23-Jun-22 6:09 PM View: | Leschly Nick Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 3,109 | -- | -- | < 1% 450.03K to 453.14K | |
| 23-Jun-22 8:19 PM View: | Jones-Burton Charlotte Director | Bluebird Bio, Inc. (BLUE) | 22-Jun-22 | Grant | 3,109 | -- | -- | 67% 4.66K to 7.77K | |
| 07-Jun-22 4:16 PM View: | Klima Thomas J Chief Commercial Officer | Bluebird Bio, Inc. (BLUE) | 03-Jun-22 | Sale | 3,753 | $3.07 | $11,535.20 | (5%) 75.19K to 71.44K | |
| 09-Mar-22 4:38 PM View: | Jones-Burton Charlotte Director | Bluebird Bio, Inc. (BLUE) | 07-Mar-22 | Grant | 4,663 | -- | -- | 100% 0 to 4.66K | |
| 03-Feb-22 6:07 PM View: | Klima Thomas J Chief Commercial Officer | Bluebird Bio, Inc. (BLUE) | 01-Feb-22 | Grant | 25,000 | -- | -- | 50% 50.19K to 75.19K |
